Understanding the rise of cardiometabolic diseases in low- and middle-income countries

Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decade...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature medicine 2019-11, Vol.25 (11), p.1667-1679
Hauptverfasser: Miranda, J. Jaime, Barrientos-Gutiérrez, Tonatiuh, Corvalan, Camila, Hyder, Adnan A., Lazo-Porras, Maria, Oni, Tolu, Wells, Jonathan C. K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1679
container_issue 11
container_start_page 1667
container_title Nature medicine
container_volume 25
creator Miranda, J. Jaime
Barrientos-Gutiérrez, Tonatiuh
Corvalan, Camila
Hyder, Adnan A.
Lazo-Porras, Maria
Oni, Tolu
Wells, Jonathan C. K.
description Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decades in high-income countries but increased in low- and middle-income countries (LMICs). The factors contributing to this rise are varied and are influenced by environmental, social, political and commercial determinants of health, among other factors. This Review focuses on understanding the rise of cardiometabolic diseases in LMICs, with particular emphasis on obesity and its drivers, together with broader environmental and macro determinants of health, as well as LMIC-based responses to counteract cardiometabolic diseases. The rise of cardiometabolic diseases in low- and middle-income countries is tied to a multitude of environmental, social and commercial determinants, which are discussed in this Review along with a strategy to counteract those factors.
doi_str_mv 10.1038/s41591-019-0644-7
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2313360287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A605546020</galeid><sourcerecordid>A605546020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c619t-36d8025fd2272a41d26bdad2376303eb9cda2a98231dcf654a56ab618ddc38aa3</originalsourceid><addsrcrecordid>eNqN0l1r1TAYB_AiipvTD-CNBATRi8y8tGl6OYYvg8FA3fAupMnTczLSZCYp6rc3xzOdR44gvWhJfv8n4enTNE8pOaaEy9e5pd1AMaEDJqJtcX-vOaRdKzDtyef79Zv0EsuhEwfNo5yvCSGcdMPD5oBXQKhkh83VZbCQctHBurBCZQ0ouQwoTsjoZF2coegxemeQres6Q0YuIB-_YlQzaHbWesAumCqRiUsoyUF-3DyYtM_w5PZ91Fy-ffPp9D0-v3h3dnpyjo2gQ8FcWElYN1nGeqZbapkYrbaM94ITDuNgrGZ6kIxTaybRtboTehRUWmu41JofNS-3dW9S_LJALmp22YD3OkBcsqpBzgVhsq_0-V_0Oi4p1Nv9VL2oZ8o7tdIelAtTLEmbTVF1IkhXm0sYqQrvUSsIkLSPASZXl3f88R5fHwuzM3sDr3YC1RT4VlZ6yVmdffzw__biate--MOuQfuyztEvxcWQdyHdQpNizgkmdZPcrNN3RYnaDJ_aDp-qw6c2w6c2HX522-FlnMH-TvyatgrYFuS6FVaQ7n7Bv6v-AGvc3yo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2313767638</pqid></control><display><type>article</type><title>Understanding the rise of cardiometabolic diseases in low- and middle-income countries</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><creator>Miranda, J. Jaime ; Barrientos-Gutiérrez, Tonatiuh ; Corvalan, Camila ; Hyder, Adnan A. ; Lazo-Porras, Maria ; Oni, Tolu ; Wells, Jonathan C. K.</creator><creatorcontrib>Miranda, J. Jaime ; Barrientos-Gutiérrez, Tonatiuh ; Corvalan, Camila ; Hyder, Adnan A. ; Lazo-Porras, Maria ; Oni, Tolu ; Wells, Jonathan C. K.</creatorcontrib><description>Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decades in high-income countries but increased in low- and middle-income countries (LMICs). The factors contributing to this rise are varied and are influenced by environmental, social, political and commercial determinants of health, among other factors. This Review focuses on understanding the rise of cardiometabolic diseases in LMICs, with particular emphasis on obesity and its drivers, together with broader environmental and macro determinants of health, as well as LMIC-based responses to counteract cardiometabolic diseases. The rise of cardiometabolic diseases in low- and middle-income countries is tied to a multitude of environmental, social and commercial determinants, which are discussed in this Review along with a strategy to counteract those factors.</description><identifier>ISSN: 1078-8956</identifier><identifier>ISSN: 1546-170X</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/s41591-019-0644-7</identifier><identifier>PMID: 31700182</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>692/499 ; 692/699/2743/137 ; 692/699/75 ; 692/700/478 ; 706/134 ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - metabolism ; Cardiovascular Diseases - pathology ; Complications and side effects ; Developing Countries ; Diabetes mellitus ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - metabolism ; Diabetes Mellitus - pathology ; Health aspects ; Health Policy ; Humans ; Income ; Infectious Diseases ; Low income groups ; Metabolic Diseases ; Metabolic Diseases - epidemiology ; Metabolic Diseases - metabolism ; Metabolic Diseases - pathology ; Molecular Medicine ; Neurosciences ; Obesity ; Review Article ; Risk analysis ; Risk Factors ; Stroke (Disease)</subject><ispartof>Nature medicine, 2019-11, Vol.25 (11), p.1667-1679</ispartof><rights>Springer Nature America, Inc. 2019</rights><rights>COPYRIGHT 2019 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Nov 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c619t-36d8025fd2272a41d26bdad2376303eb9cda2a98231dcf654a56ab618ddc38aa3</citedby><cites>FETCH-LOGICAL-c619t-36d8025fd2272a41d26bdad2376303eb9cda2a98231dcf654a56ab618ddc38aa3</cites><orcidid>0000-0002-4738-5468</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41591-019-0644-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41591-019-0644-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31700182$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miranda, J. Jaime</creatorcontrib><creatorcontrib>Barrientos-Gutiérrez, Tonatiuh</creatorcontrib><creatorcontrib>Corvalan, Camila</creatorcontrib><creatorcontrib>Hyder, Adnan A.</creatorcontrib><creatorcontrib>Lazo-Porras, Maria</creatorcontrib><creatorcontrib>Oni, Tolu</creatorcontrib><creatorcontrib>Wells, Jonathan C. K.</creatorcontrib><title>Understanding the rise of cardiometabolic diseases in low- and middle-income countries</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><addtitle>Nat Med</addtitle><description>Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decades in high-income countries but increased in low- and middle-income countries (LMICs). The factors contributing to this rise are varied and are influenced by environmental, social, political and commercial determinants of health, among other factors. This Review focuses on understanding the rise of cardiometabolic diseases in LMICs, with particular emphasis on obesity and its drivers, together with broader environmental and macro determinants of health, as well as LMIC-based responses to counteract cardiometabolic diseases. The rise of cardiometabolic diseases in low- and middle-income countries is tied to a multitude of environmental, social and commercial determinants, which are discussed in this Review along with a strategy to counteract those factors.</description><subject>692/499</subject><subject>692/699/2743/137</subject><subject>692/699/75</subject><subject>692/700/478</subject><subject>706/134</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - metabolism</subject><subject>Cardiovascular Diseases - pathology</subject><subject>Complications and side effects</subject><subject>Developing Countries</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - metabolism</subject><subject>Diabetes Mellitus - pathology</subject><subject>Health aspects</subject><subject>Health Policy</subject><subject>Humans</subject><subject>Income</subject><subject>Infectious Diseases</subject><subject>Low income groups</subject><subject>Metabolic Diseases</subject><subject>Metabolic Diseases - epidemiology</subject><subject>Metabolic Diseases - metabolism</subject><subject>Metabolic Diseases - pathology</subject><subject>Molecular Medicine</subject><subject>Neurosciences</subject><subject>Obesity</subject><subject>Review Article</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Stroke (Disease)</subject><issn>1078-8956</issn><issn>1546-170X</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqN0l1r1TAYB_AiipvTD-CNBATRi8y8tGl6OYYvg8FA3fAupMnTczLSZCYp6rc3xzOdR44gvWhJfv8n4enTNE8pOaaEy9e5pd1AMaEDJqJtcX-vOaRdKzDtyef79Zv0EsuhEwfNo5yvCSGcdMPD5oBXQKhkh83VZbCQctHBurBCZQ0ouQwoTsjoZF2coegxemeQres6Q0YuIB-_YlQzaHbWesAumCqRiUsoyUF-3DyYtM_w5PZ91Fy-ffPp9D0-v3h3dnpyjo2gQ8FcWElYN1nGeqZbapkYrbaM94ITDuNgrGZ6kIxTaybRtboTehRUWmu41JofNS-3dW9S_LJALmp22YD3OkBcsqpBzgVhsq_0-V_0Oi4p1Nv9VL2oZ8o7tdIelAtTLEmbTVF1IkhXm0sYqQrvUSsIkLSPASZXl3f88R5fHwuzM3sDr3YC1RT4VlZ6yVmdffzw__biate--MOuQfuyztEvxcWQdyHdQpNizgkmdZPcrNN3RYnaDJ_aDp-qw6c2w6c2HX522-FlnMH-TvyatgrYFuS6FVaQ7n7Bv6v-AGvc3yo</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Miranda, J. Jaime</creator><creator>Barrientos-Gutiérrez, Tonatiuh</creator><creator>Corvalan, Camila</creator><creator>Hyder, Adnan A.</creator><creator>Lazo-Porras, Maria</creator><creator>Oni, Tolu</creator><creator>Wells, Jonathan C. K.</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4738-5468</orcidid></search><sort><creationdate>20191101</creationdate><title>Understanding the rise of cardiometabolic diseases in low- and middle-income countries</title><author>Miranda, J. Jaime ; Barrientos-Gutiérrez, Tonatiuh ; Corvalan, Camila ; Hyder, Adnan A. ; Lazo-Porras, Maria ; Oni, Tolu ; Wells, Jonathan C. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c619t-36d8025fd2272a41d26bdad2376303eb9cda2a98231dcf654a56ab618ddc38aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>692/499</topic><topic>692/699/2743/137</topic><topic>692/699/75</topic><topic>692/700/478</topic><topic>706/134</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - metabolism</topic><topic>Cardiovascular Diseases - pathology</topic><topic>Complications and side effects</topic><topic>Developing Countries</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - metabolism</topic><topic>Diabetes Mellitus - pathology</topic><topic>Health aspects</topic><topic>Health Policy</topic><topic>Humans</topic><topic>Income</topic><topic>Infectious Diseases</topic><topic>Low income groups</topic><topic>Metabolic Diseases</topic><topic>Metabolic Diseases - epidemiology</topic><topic>Metabolic Diseases - metabolism</topic><topic>Metabolic Diseases - pathology</topic><topic>Molecular Medicine</topic><topic>Neurosciences</topic><topic>Obesity</topic><topic>Review Article</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Stroke (Disease)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miranda, J. Jaime</creatorcontrib><creatorcontrib>Barrientos-Gutiérrez, Tonatiuh</creatorcontrib><creatorcontrib>Corvalan, Camila</creatorcontrib><creatorcontrib>Hyder, Adnan A.</creatorcontrib><creatorcontrib>Lazo-Porras, Maria</creatorcontrib><creatorcontrib>Oni, Tolu</creatorcontrib><creatorcontrib>Wells, Jonathan C. K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miranda, J. Jaime</au><au>Barrientos-Gutiérrez, Tonatiuh</au><au>Corvalan, Camila</au><au>Hyder, Adnan A.</au><au>Lazo-Porras, Maria</au><au>Oni, Tolu</au><au>Wells, Jonathan C. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Understanding the rise of cardiometabolic diseases in low- and middle-income countries</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><addtitle>Nat Med</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>25</volume><issue>11</issue><spage>1667</spage><epage>1679</epage><pages>1667-1679</pages><issn>1078-8956</issn><issn>1546-170X</issn><eissn>1546-170X</eissn><abstract>Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decades in high-income countries but increased in low- and middle-income countries (LMICs). The factors contributing to this rise are varied and are influenced by environmental, social, political and commercial determinants of health, among other factors. This Review focuses on understanding the rise of cardiometabolic diseases in LMICs, with particular emphasis on obesity and its drivers, together with broader environmental and macro determinants of health, as well as LMIC-based responses to counteract cardiometabolic diseases. The rise of cardiometabolic diseases in low- and middle-income countries is tied to a multitude of environmental, social and commercial determinants, which are discussed in this Review along with a strategy to counteract those factors.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>31700182</pmid><doi>10.1038/s41591-019-0644-7</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-4738-5468</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-8956
ispartof Nature medicine, 2019-11, Vol.25 (11), p.1667-1679
issn 1078-8956
1546-170X
1546-170X
language eng
recordid cdi_proquest_miscellaneous_2313360287
source MEDLINE; Springer Nature - Complete Springer Journals; Nature Journals Online
subjects 692/499
692/699/2743/137
692/699/75
692/700/478
706/134
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - metabolism
Cardiovascular Diseases - pathology
Complications and side effects
Developing Countries
Diabetes mellitus
Diabetes Mellitus - epidemiology
Diabetes Mellitus - metabolism
Diabetes Mellitus - pathology
Health aspects
Health Policy
Humans
Income
Infectious Diseases
Low income groups
Metabolic Diseases
Metabolic Diseases - epidemiology
Metabolic Diseases - metabolism
Metabolic Diseases - pathology
Molecular Medicine
Neurosciences
Obesity
Review Article
Risk analysis
Risk Factors
Stroke (Disease)
title Understanding the rise of cardiometabolic diseases in low- and middle-income countries
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T04%3A07%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Understanding%20the%20rise%20of%20cardiometabolic%20diseases%20in%20low-%20and%20middle-income%20countries&rft.jtitle=Nature%20medicine&rft.au=Miranda,%20J.%20Jaime&rft.date=2019-11-01&rft.volume=25&rft.issue=11&rft.spage=1667&rft.epage=1679&rft.pages=1667-1679&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/s41591-019-0644-7&rft_dat=%3Cgale_proqu%3EA605546020%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2313767638&rft_id=info:pmid/31700182&rft_galeid=A605546020&rfr_iscdi=true